A Novel TARP-Promoter-Based Adenovirus against Hormone-Dependent and Hormone-Refractory Prostate Cancer
Authors:
Open Access
- 31 August 2004
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 10 (2) , 355-364
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Molecular characterization of human prostate carcinoma cell linesThe Prostate, 2003
- Transcription-targeted gene therapy for androgen-independent prostate cancerCancer Gene Therapy, 2002
- Superior Tissue-Specific Expression from Tyrosinase and Prostate-Specific Antigen Promoters/Enhancers in Helper-Dependent Compared with First-Generation Adenoviral VectorsHuman Gene Therapy, 2002
- A Tissue-Specific Enhancer of the Prostate-Specific Membrane Antigen Gene, FOLH1Genomics, 2001
- Creation of a new transgene cloning site near the right ITR of Ad5 results in reduced enhancer interference with tissue-specific and regulatable promotersGene Therapy, 2001
- Insulation of a conditionally expressed transgene in an adenoviral vectorGene Therapy, 1999
- Modulation of the Specificity and Activity of a Cellular Promoter in an Adenoviral VectorHuman Gene Therapy, 1997
- A 5′ element of the chicken β-globin domain serves as an insulator in human erythroid cells and protects against position effect in DrosophilaCell, 1993
- The human androgen receptor: Domain structure, genomic organization and regulation of expressionJournal of Steroid Biochemistry, 1989
- The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer elementCell, 1983